Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
D Craig Allred, Robert W Carlson, Donald A Berry, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendations
Robert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Journal of the American College of Surgeons
|
September 27, 2005
Image-detected breast cancer: state of the art diagnosis and treatment
Melvin J Silverstein, Michael D Lagios, Abram Recht, et al.
The Lancet. Oncology
|
December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S Albain, William E Barlow, Steven Shak, et al.
Archives of Pathology & Laboratory Medicine
|
June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of the National Cancer Institute
|
March 22, 2015
Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer
Richard R Love, Adriano V Laudico, Nguyen Van Dinh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2010
Postmenopausal hormone therapy: an Endocrine Society scientific statement
Richard J Santen, D Craig Allred, Stacy P Ardoin, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
D Craig Allred, Robert W Carlson, Donald A Berry, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendations
Robert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031
Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Journal of the American College of Surgeons
|
September 27, 2005
Image-detected breast cancer: state of the art diagnosis and treatment
Melvin J Silverstein, Michael D Lagios, Abram Recht, et al.
The Lancet. Oncology
|
December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S Albain, William E Barlow, Steven Shak, et al.
Archives of Pathology & Laboratory Medicine
|
June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of the National Cancer Institute
|
March 22, 2015
Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer
Richard R Love, Adriano V Laudico, Nguyen Van Dinh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 23, 2010
Postmenopausal hormone therapy: an Endocrine Society scientific statement
Richard J Santen, D Craig Allred, Stacy P Ardoin, et al.
Page
of 10